Company intelligence / Profile preview
Lipella Pharmaceuticals
Pittsburgh, Pennsylvania, United Stateslipella.com ↗
- Ownership
- Public · LIPO
- Employees
- ~7
- Development stage
- Phase 2
01
Overview
Lipella has completed a Phase 2a trial of LP‑10 in hemorrhagic cystitis and is planning a Phase 2b trial. INDs are approved for LP‑310 and LP‑410, with Phase 2a studies in oral lichen planus and oral GvHD expected to begin in late 2024/early 2025. The company’s proprietary liposomal platform is protected by patents through at least 2035.
- Therapeutic areas
- OncologyImmunologyNephrology
- Modalities
- Small moleculeLiposomal drug delivery therapyImmunoglobulin therapy (for LP-50)
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
No major pharma partnerships disclosed as of June 2025; open to strategic partnerships/licensing
04
Financials
- Market cap
- $2.3K
- Total revenue
- $0
- Enterprise value
- $-1.6M
Beyond the preview
Go deeper on Lipella Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lipella Pharmaceuticals.